Hims & Hers Health (HIMS) Expands into Canada with a New Weight Loss Program

Hims & Hers Health, Inc. (NYSE:HIMS) is one of the Stocks With Huge Catalysts on the Horizon. On July 9, Hims & Hers Health, Inc. announced expanding into Canada with a new affordable weight loss program. The timing of this expansion has been matched with the first-ever availability of generic semaglutide, a popular weight loss medication.

Management noted that Canadians face high costs and lack access to proven weight loss treatments, whereas branded semaglutide costs more than C$200. The availability of generics is expected to lower prices and make treatment more accessible. Hims & Hers Health, Inc. will offer these generic and low-cost options through its online platform, providing 24/7 access to licensed providers and personalized care plans.

Hims & Hers Health (HIMS) Expands into Canada with a New Weight Loss Program

A nurse in a telehealth platform talking with a patient on video call for consultation.

Moreover, the company’s recent acquisition of European health platform ZAVA reflects its strategic plan to expand globally.

Hims & Hers Health, Inc. is a digital health platform that connects consumers to licensed healthcare professionals for personalized care.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

This article is originally published at Insider Monkey.